chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DIZZY/LIGHTHEADED; RUBBER LEGS; HEART RACING; LOOKED WHITE; NEAR SYNCOPAL EPISODE/NEARLY PASSED OUT; INTERMITTENTLY FEELING HOT; FLUSH; FOGGY; NOT FEELING WELL; BLURRY VISION; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: 20-JUN-2021) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced blurry vision. On 01-APR-2021, the subject experienced intermittently feeling hot. On 01-APR-2021, the subject experienced flush. On 01-APR-2021, the subject experienced foggy. On 01-APR-2021, the subject experienced not feeling well. On 02-APR-2021, the subject experienced near syncopal episode/nearly passed out. On 02-APR-2021, the subject experienced heart racing. On 02-APR-2021, the subject experienced looked white. On 03-APR-2021, the subject experienced dizzy/lightheaded. On 03-APR-2021, the subject experienced rubber legs. On 05-APR-2021, Laboratory data included: ECG (NR: not provided) UNKNOWN (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from near syncopal episode/nearly passed out on 02-APR-2021, heart racing on 04-APR-2021, and blurry vision on 30-MAR-2021, was recovering from intermittently feeling hot, flush, foggy, not feeling well, dizzy/lightheaded, and rubber legs, and the outcome of looked white was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is considered non serious.
Severe headache on one side of the head/ Had the same headache on the other side of the head/ pretty bad pain in her head, on both sides; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headache on one side of the head/ Had the same headache on the other side of the head/ pretty bad pain in her head, on both sides) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Cholesterol high. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced HEADACHE (Severe headache on one side of the head/ Had the same headache on the other side of the head/ pretty bad pain in her head, on both sides). The patient was treated with PARACETAMOL (TYLENOL) on 14-Mar-2021 for Headache, at an unspecified dose and frequency and HYDROCORTISONE on 15-Mar-2021 for Headache, at a dose of Half pill. At the time of the report, HEADACHE (Severe headache on one side of the head/ Had the same headache on the other side of the head/ pretty bad pain in her head, on both sides) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medications included blood pressure medication and cholesterol medication.
Fever; Massive migraine; Entire right upper arm swollen; Entire right upper arm hot to touch for past 2 days; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03May2021 at 16:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 03May2021 (also reported as at 15:45),  the patient experienced fever, massive migraine, entire right upper arm swollen and hot to touch for past 2 days. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, massive migraine, entire right upper arm swollen and hot to touch for past 2 days was unknown at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient came in Friday 4.15.22 to get her second dose of Shingrix.  She states that on Sunday a red bruise like circle appeared on her arm.  It was hot to the touch and sore.  It is several inches below the injection site.  The circle is getting larger, but the soreness has decreased.  She took benadryl yesterday but did not do anything.  Today it is larger, but not as hot to the touch. It is slightly sore but decreasing compared to Sunday. This did not occur to her after her first dose
PATIENT STATED HAS BEEN WOOZY IN THE PAST WITH VACCINATIONS BUT SAID NOT FOR QUITE SOMETIME.  RIGHT AFTER THE IMMUNIZATION, PATIENT STARTED TO LOSE CONSCIOUSNESS BUT SOON CAME TO AGAIN AND SAID HE FELT THAT HE HAD A DREAM.  PATIENT SAT AND WAS OK SHORTLY THEREAFTER
t102 @ 12MN 8hrs p/vax cough + mucus-fever persisted 30hrs w/pt c/o exhuastion & sleeping most of the time (x48hrs) according to pts wife
"covid arm"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION ("covid arm") in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION ("covid arm"). At the time of the report, VACCINATION SITE REACTION ("covid arm") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication information was reported. No Treatment medications were provided.   This case was linked to MOD-2021-370414.
Have been experiencing lethargy and inflammation of skin and joints. Did not connect it to the vaccine until I did some reading recently. Had a really bad flareup in Nov. and affected my skin my joints and that is when I saw my doctor. About 2 months after getting my Moderna booster inflammation in joints and skin increased. Still having the lethargy. I will good for a while then there will be a spike and I don't feel good for a while. Not sure if it is the vaccine but before the vaccine I did have weeks of time where I felt bad like this or had sustained inflammation.
Fever (102), mild wheeze, ear infection. Rx: Albuterol neb, Amoxicillin.
the day following a routine PE & vax pt reported soreness in lt arm & of a stiff neck;
Pt with mild orthostatic hypotension 48 hours after receiving vaccination, feeling "dizzy".
After about two days, began to experience diahhrea for three months.  Consulted with Gastroenterologist who put me on CREON. I am still trying to get diaahrea under control.
On 8/1/13 began to have photo sensitivity and felt off balance while out hiking; felt dizzy when turning head. Took a fall and hit head. On 8/7/13 became nauseous/vomiting headache, hands and elbows became tingling - went to DR immediately - DR. felt it was a migraine related event. Sent home - continued to have photo sensitivity, balance problems. Returned to doctor 8/13/13. Improving slowly - remains off work.
Maternal exposure during pregnancy; Lethargy; Severe fatigue; Tiredness; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during pregnancy), LETHARGY (Lethargy), FATIGUE (Severe fatigue) and FATIGUE (Tiredness) in a 36-year-old female patient (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-Apr-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during pregnancy), LETHARGY (Lethargy), FATIGUE (Severe fatigue) and FATIGUE (Tiredness). The cesarean delivery occurred, which was reported as Premature. For neonate 1, the birth weight was 2268 grams (5lbs). The outcome was reported as Pre-Term Birth NOS. Baby was conceived through IVF, Low AMH is culprit of infertility.  Water broke and chose to do a C-section. Live, pre-term birth. Length - 18 inches.  Pregnancy related complication was Baby was measuring small- labeled as IUGR. At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (Maternal exposure during pregnancy) had resolved and LETHARGY (Lethargy), FATIGUE (Severe fatigue) and FATIGUE (Tiredness) outcome was unknown.            No concomitant medications was reported. Treatment medications was not provided   This case was linked to MOD-2021-256756, MOD-2021-051792 (Patient Link).
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 79-year-old, elderly patient of an unspecified gender. It was reported that, the FLUCELVAX QIVc vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 19-Oct-2018, the patient was administered FLUCELVAX QIVc [route of administration: intramuscular, anatomical location: left deltoid, batch number: 252230, expiry date: 31-May-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805442 was crossed linked to original case 201804863 due to same reporter.
rash covering their whole body; This spontaneous report as received from a physician refers to a 20-month-old patient. There was no information about the patient's medical history, concurrent conditions or concomitant medication.  On an unknown date, the patient was vaccinated with a second hepatitis a vaccine, inactivated (VAQTA)prefilled syringe,dose:0.5 milliliter, lot # T013205, expiration date not reported, but upon internal validation established as 03-DEC-2021,intramuscularly for prophylaxis reported as hep A vaccination.    On an unknown date, the patient experienced rash covering their whole body. The patient received unspecified treatment. The outcome of rash was unknown.     The causal relationship between the aforementioned event hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was not reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: T013205; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2102USA008560:
The day after the vaccine, symptoms were headache, sore throat, high fever, trembling and vomiting, very swollen lymph nodes.  Treated with a steroid, epinephrine, vicodin, an antibiotic, and benadryl and 4 hours on an IV.
Information has been received from a pharmacist concerning his daughter, an 18 year old female with a history of attention deficit disorder and no drug reactions/allergies who was vaccinated intramuscularly with 3 doses of GARDASIL on 12-AUG-2009, 12-OCT-2009 and 29-JAN-2010. Concomitant therapy included VYVANSE and hormonal contraceptives (unspecified). The first and second doses of GARDASIL hurt at injection site. The third dose hurt more than usual at the injection site. On 31-JAN-2010 the patient complained of severe stomach pain and not feeling good. In the evening of 01-FEB-2010 the patient had an overwhelming sense of depression and started balling and crying out of the blue. The patient had also been tired. There were no laboratory diagnostic studies performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Case number PHEH2014US014007 is an initial spontaneous report received from a health care professional on 15 Jul 2014. This report refers to a 11-year-old female patient. The patient received only Men CWY liquid conjugate component of MENVEO (batch number: not reported) intramuscularly on 15 Jul 2014. No adverse events were reported following this medication error.
Information has been received from the mother of a 13 year old female with a history of mood disorder who on unspecified dates received the first and second doses of GARDASIL.  On 16-SEP-2008 was vaccinated with a third dose of GARDASIL.  There was no concomitant medication.  After she received the 3rd dose on 16-SEP-2008, later that day she felt pain in her back and grabbed her spinal column.  The patient lowered herself down to the floor to lie flat on the ground.  She became unconscious and rhythmically moved one of her arms back and forth toward her head.  This movement then stopped and she re-gained consciousness and opened her eyes.  The entire episode lasted only about 1 to 2 minutes.  She seemed fine and normal shortly thereafter.  As a precaution she was taken to the Emergency Department of a local hospital where she had a number of tests.  All of the test results were normal.  She did not have to be admitted as an in-patient to the hospital.  She has seemed normal ever since this incident occurred.  She subsequently went to a cardiologist and a neurologist who specializes in pediatric epilepsy.  The patient's mother said that the neurologist would like to do further testing of her daughter.  Additional information has been requested.
Fever (102.8°F), improved with Tylenol, lasted about 4 hours
Patient reported that she experienced blurry vision one day after receiving the Janssen COVID-19 vaccine, around 2:00 pm on 3/17/2021. She expressed concern that this might be related to the COVID-19 vaccine. She said it feels like there's something in her eye that's irritating it. I asked if she has seasonal allergies, and she said yes. She does not take anything for allergies. I advised her to try Visine eye drops. After consulting with Dr, I also advised her to take an over the counter antihistamine like Zyrtec, Allegra, or Claritin. Patient is diabetic, so we asked her to check her blood glucose as well. Patient reports that the Visine helped. Her blood sugar was 189. She reported chills and a mild fever. She took Tylenol and it brought her temperature down to of 99.6 F. I advised her to call me if any of her symptoms get worse or do not improve.
Extreme nausea, aches, malaise, headache, fatigue lasting one day  Ongoing headaches, fatigue, malaise, mental fog lasting 4+ days after vaccine
Irregular heartbeat. Skip heartbeats.  Went to 180/mins for a few mins while sitting still. It happened several times.  I went to the hospital and ER but no cause can be found.  I scheduled the cardiologist and nothing found.  I wore the Zio heart monitor for two weeks from June 3rd to June 17th. The device was sent to the doctor and no result yet. I still feel the skip and irregular beats every day.  Hope I can get some results this time.
mom states pt had t103 ax temp responsive to tepid baths & APAP had rash devel lasting 1 1/2 days on cheeks, arms, legs tummy also swollen hands/feet x 1 1/2 day; temp lasted 1 1/2 days;
On 11/23/19 presented with fever, chills, N/V, headache, backache. Went to ER, had abdominal sonogram and sent home with suspected GB attack. Returned to ER same day + admitted. Had routine work up + an abd. CT. Liver enzymes elevated. Admitted + several days passed. Decreased WBC + decreased platelets. Cholecystectomy 11/29/20. What triggered the attack???
Started with hives at 12:00 noon. Worse now, face flushed. No difficulty breathing (3:30 PM) on way home from work. Will stop by to buy BENADRYL and call to report result. BENADRYL relieved symptoms.
Arm became swollen, lymph node under are and breast tissue was enlarged. This began the day of the vaccination. Mouth sores on tongue began the 5th. painful tongue blisters, loss of taste. This continued for over a week. Tongue blisters are still present, but healing. Tasted has returned. Circulation issues began, fingers and toes going numb and turning white has continued since event.
Lyme Disease from a tick bite in Aug for 3 weeks, UTI in Jun and July. Mammogram in Sept 2021 - chest pain left side, achy pain, chest wall pain ER  - 9/9/2021. Had a scarlet fever as a child.
After patient received vaccines patient slumped in the waiting room chair and began having jerking motions. Patient was transferred via wheelchair to stretcher. Placed with legs above heart. Medical doctor and RN called to the scene and monitored vital signs. Discharged after vital signs normal and lightheadedness and dizziness resolved.
Around 4/19/21 pt started experiencing shortness of breath that increased to the point of gasping for breath on 4/25/21.  Her daughter (me!) visited and immediately called her pulmonologist who requested she immediately go to the hospital.  The ER said she had an enlarged heart, and was checked in to the cardiac unit.  Tests showed she had acute systolic and diastolic heart failure.  She was first put on diuretics while further tests were done, and Tikosyn was later added to her list of regular medications.  Within a week she was able to go home.  She was on oxygen prior to this event from the pulmonary fibrosis, and was able to return to her prior settings on her oxygen concentrator within five days, but her ongoing discomfort has stayed at a heightened level, and her level of activity has not returned to her normal.  Please note:  she is an 84 year old with pulmonary fibrosis.  It is not possible for me as her daughter (not a medical professional) to know if the original diagnosis of heart inflammation was related to her vaccination, but she had been relatively stable for more than six months prior to this hospitalization event and the onset of this sequence of events was identified by the doctors as being of unknown origin at that time.
2 1/2 inches x 2 1/2 inch area of Erythema / warmth and induration over right thigh (site of DTAP injection) 24 hours after administration, no fever, no nausea, no vomiting, Benadryl and Motrin given.
Developed shingles,05/2022- went into my eye and had to go to eye specialist so I did t loose sight in my right eye  Covid 12/2021
Very sore arm with a large, hard raised welt, and a large visible bruise (the bruise and some hardness is still very visible today 8/30/21, 12 days after vaccine was received).  Starting the evening of 8/20/21, I have had severe dizziness that worsens with bending over, laying down, or looking to the right and especially laying on my right side.  Dizziness persists to this day.
Subsequent to receiving one dose of varicella virus vaccine live the pt broke out in a case of breakthrough chickenpox that blistered and scabbed over. Pt was treated with acyclovir.
Daily Persistent Headache, Daily Aggravated Asthma/Tight Chest, Daily Metal taste in mouth.  (All symptoms are experienced daily since injection).    Also experienced flu-like symptoms day after injection for approximately 24 hours.
2 minutes after administration, patient was standing and suddenly experienced acute pain shooting down her spine into the back, hip and legs. She sat down and winced in pain. She experienced extreme discomfort which led to temporary shortness of breath, which resolved after 1 minute. The patient's husband and I helped the patient feel less anxious and then the patient's breathing improved. After 5 minutes of staying seated, the patient said her muscle pain in back/hip/legs was improved but pain still present. The patient was monitored for 15 minutes and displayed no further signs of shortness of breath. No medication treatment was administered. After monitoring, the patient and her husband were able to walk out of the pharmacy. The patient reported never having experiencing symptoms like these in the past.
It was reported that a pt (1 of 2) received a TD ADS Adult vaccination. The pt experienced swelling and bruising. No specifics were provided. Further information is being requested.
25g 1" needed used - 0.5 ml given in deltoid muscle (left) - immediate swelling and darkness started around injection site - patient complained of soreness at injection site - soreness went to shoulder blade area of left shoulder - bruised area (circle) with pin and point dot at injection area. Neck stiffness and numbness in hands through 10/14/13.
2 months after the injections I got shingles. I was unable to get in with my skin doctor, so I contacted my internist who prescribed antivirals. I took them and the shingles ran its course and disappeared after a couple weeks. I have had shingles before, so I am able to identify it. This time was different because usually I experience a burning sensation but this time it was as if my nerves were hypersensitive about 4 days before they erupted
This spontaneous report as received from a consumer (patient's mother) refers to a 13 year old male patient with no pertinent medical history and no drug reactions or allergies. On an unknown dates, the patient was vaccinated with the first and second dose of GARDASIL injection (dose, route of administration, anatomical location and interval were not reported). Approximately in September 2014 (reported as "completed his GARDASIL series 1 year ago"), he was vaccinated with the third dose of GARDASIL injection (dose, route of administration, anatomical location and interval were not reported). There were no concomitant medications. Approximately in December 2014 (reported as "3 to 4 months after completion of their third and final dose of the vaccine"), the patient developed severe acne on his face and back. He was treated with ACCUTANE. It was reported, that the patient sought medical attention - office visit. The outcome of the event was reported as not recovered/not resolved. The relatedness between the event and GARDASIL was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Within 10 minutes of receiving immunizations, child was dyspeneic and pale. gave epinephrine subq and 911 called. Transferred to Hospital where he was kept for 24 hrs.